Thift Limited – Trademark Portfolio

Entity Type: 16

Thift Limited has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include THIFT. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 36 (Insurance & Financial) and Class 5 (Pharmaceuticals). This trademark owner is based in Arundel.

3/60 Newheath Drive

Arundel 4214 , AU

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VITOM
VITOM
Abandoned 2023
THIFT
THIFT
Registered 2023

Trademark Classifications

Thift Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

28
Toys & Sporting Goods (1 filing)

Games and playthings; gymnastic and sporting articles; decorations for Christmas trees

Frequently Asked Questions

How many trademarks does Thift Limited have?

Thift Limited has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.

What trademark classes does Thift Limited file in?

Thift Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 5 (Pharmaceuticals), Class 28 (Toys & Sporting Goods). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Thift Limited's most well-known trademarks?

Thift Limited's registered trademark portfolio includes well-known marks such as THIFT. These are among 1 currently registered trademark in the portfolio.

What is Thift Limited's trademark registration success rate?

Thift Limited has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.